e-Therapeutics plc Director/PDMR Shareholding (6882O)

TIDMETX

RNS Number : 6882O

e-Therapeutics plc

22 August 2017

E-THERAPEUTICS PLC

("e-therapeutics" or the "Company")

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS

DISCHARGING MANAGERIAL RESPONSIBILITIES

Oxford, UK, 22 August 2017 - e-therapeutics plc (AIM: ETX), the computer-based drug discovery platform company, announces that it has received notifications from two of its directors that they have purchased, in aggregate, 520,000 shares in the Company at a price of 10.6 pence per share. The purchases took place today.

The number of ordinary shares purchased by each director is set out below:

 
 Director      Number 
                of shares 
                purchased 
------------  ----------- 
 Iain Ross        250,000 
------------  ----------- 
 Ray Barlow       270,000 
------------  ----------- 
 

Mr Ross purchased the shares through his self-invested personal pension (SIPP) and, following these trades, the beneficial interests of those directors in ordinary shares of ETX are as follows:

 
 Director      Number       Percentage 
                of shares    of issued 
                held         share 
                             capital 
------------  -----------  ----------- 
 Iain Ross      1,250,000        0.47% 
------------  -----------  ----------- 
 Ray Barlow     1,100,000        0.41% 
------------  -----------  ----------- 
 

The notifications below, made in accordance with the requirements of the EU Market Abuse Regulation, provide further details:

 
 1    Details of the person discharging managerial 
       responsibilities/person closely associated 
---  ------------------------------------------------------------------- 
 a)   Name                      Iain Ross 
---  ------------------------  ----------------------------------------- 
 2    Reason for the notification 
---  ------------------------------------------------------------------- 
 a)   Position/status           Non-Executive Chairman 
---  ------------------------  ----------------------------------------- 
 b)   Initial notification/     Initial notification 
       Amendment 
---  ------------------------  ----------------------------------------- 
 3    Details of the issuer, emission allowance market 
       participant, auction platform, auctioneer or 
       auction monitor 
---  ------------------------------------------------------------------- 
 a)   Name                      e-therapeutics plc 
---  ------------------------  ----------------------------------------- 
 b)   LEI                       21380049RHSSJXWKYT18 
---  ------------------------  ----------------------------------------- 
 4    Details of the transaction(s): section to be 
       repeated for (i) each type of instrument; (ii) 
       each type of transaction; (iii) each date; and 
       (iv) each place where transactions have been 
       conducted 
---  ------------------------------------------------------------------- 
 a)   Description of            Ordinary shares of 0.1 pence 
       the financial 
       instrument, type          ISIN: GB00B2823H99 
       of instrument 
       Identification 
       code 
---  ------------------------  ----------------------------------------- 
 b)   Nature of the             Purchase of shares through self-invested 
       transaction               personal pension (SIPP) 
---  ------------------------  ----------------------------------------- 
 c)   Price(s) and              250,000 ordinary shares at a price 
       volume(s)                 of 10.6 pence per share 
---  ------------------------  ----------------------------------------- 
 d)   Aggregated information    N/A 
       - Aggregated 
       volume 
       - Price 
---  ------------------------  ----------------------------------------- 
 e)   Date of the transaction   22 August 2017 
---  ------------------------  ----------------------------------------- 
 f)   Place of the              London Stock Exchange, AIM (XLON) 
       transaction 
---  ------------------------  ----------------------------------------- 
 
 
 1    Details of the person discharging managerial 
       responsibilities/person closely associated 
---  ------------------------------------------------------------- 
 a)   Name                      Ray Barlow 
---  ------------------------  ----------------------------------- 
 2    Reason for the notification 
---  ------------------------------------------------------------- 
 a)   Position/status           Chief Executive Officer 
---  ------------------------  ----------------------------------- 
 b)   Initial notification/     Initial notification 
       Amendment 
---  ------------------------  ----------------------------------- 
 3    Details of the issuer, emission allowance market 
       participant, auction platform, auctioneer or 
       auction monitor 
---  ------------------------------------------------------------- 
 a)   Name                      e-therapeutics plc 
---  ------------------------  ----------------------------------- 
 b)   LEI                       21380049RHSSJXWKYT18 
---  ------------------------  ----------------------------------- 
 4    Details of the transaction(s): section to be 
       repeated for (i) each type of instrument; (ii) 
       each type of transaction; (iii) each date; and 
       (iv) each place where transactions have been 
       conducted 
---  ------------------------------------------------------------- 
 a)   Description of            Ordinary shares of 0.1 pence 
       the financial 
       instrument, type          ISIN: GB00B2823H99 
       of instrument 
       Identification 
       code 
---  ------------------------  ----------------------------------- 
 b)   Nature of the             Purchase of shares 
       transaction 
---  ------------------------  ----------------------------------- 
 c)   Price(s) and              270,000 ordinary shares at a price 
       volume(s)                 of 10.6 pence per share 
---  ------------------------  ----------------------------------- 
 d)   Aggregated information    N/A 
       - Aggregated 
       volume 
       - Price 
---  ------------------------  ----------------------------------- 
 e)   Date of the transaction   22 August 2017 
---  ------------------------  ----------------------------------- 
 f)   Place of the              London Stock Exchange, AIM (XLON) 
       transaction 
---  ------------------------  ----------------------------------- 
 

For further information, please contact:

 
 e-therapeutics plc                 Tel: [phone] 
  Ray Barlow, Chief Executive        883 125 
  Officer                            www.etherapeutics.co.uk 
  Steve Medlicott, Finance 
  Director 
 Numis Securities Limited           Tel: +44 (0) 207 
  Michael Meade/Freddie Barnfield    260 1000 
  (Corporate Finance)                www.numis.com 
  James Black (Corporate 
  Broking) 
 Instinctif Partners                Tel: +44 (0) 207 
  Melanie Toyne Sewell/Alex          457 2020 
  Shaw                               Email: [e-mail] 
 

About e-therapeutics plc

We are an Oxford-based company with a unique and powerful computer-based drug discovery platform and a specialised approach to network biology.

Our novel methodology and our Discovery Engine allow us to discover new and better drugs in a more efficient and effective way.

e-therapeutics is headquartered in Oxford. For more information about the Company please visit www.etherapeutics.co.uk.

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHLLFLVTFIFFID

(END) Dow Jones Newswires

August 22, 2017 09:13 ET (13:13 GMT)